Form 4: Hims & Hers CFO Oluyemi Okupe Exercises Options and Sells Shares Under Pre-Arranged Trading Plan

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, executed a pre-planned transaction on May 28, 2025, involving the exercise of stock options and the subsequent sale of Class A Common Stock.

Summary

• Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., exercised options to acquire 6,437 shares of Class A Common Stock at an exercise price of $5.01 per share on May 28, 2025.
• Concurrently, Mr. Okupe sold 11,581 shares of Class A Common Stock at an average weighted price of $52.9779 per share on May 28, 2025, with prices ranging from $52.745 to $53.255.
• These stock option exercises and sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024.
• Additionally, 1,056 shares were acquired on May 20, 2025, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.
• 70,575 shares that were previously held directly by Mr. Okupe were transferred to the Oluyemi Okupe Separate Property Trust dated September 1, 2021.
• Following these reported transactions, Mr. Okupe directly holds 39,153 shares of Class A Common Stock and indirectly holds 70,575 shares through the Oluyemi Okupe Separate Property Trust.
• Mr. Okupe retains beneficial ownership of 386,970 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale can sometimes be viewed negatively, the fact that it was executed under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling. The CFO also retains significant direct and indirect ownership, along with a large number of unexercised options, indicating continued alignment with the company's performance.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which indicates a systematic and planned sale rather than a reaction to immediate market conditions or non-public information.
• The exercise of stock options at a low price ($5.01) and subsequent sale at a significantly higher market price ($52.9779) demonstrates a profitable realization for the insider.
• The CFO continues to hold a substantial number of shares directly and indirectly (109,728 shares total), along with a significant number of unexercised options (386,970), indicating continued alignment with shareholder interests.
• The acquisition of shares through the Employee Stock Purchase Plan (ESPP) on May 20, 2025, shows ongoing participation in employee benefit programs.

Negatives

• The sale of 11,581 shares by a Chief Financial Officer, even if pre-planned, represents a reduction in direct insider ownership.

Future Outlook

NA

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• Transfer of 70,575 shares from direct ownership to the Oluyemi Okupe Separate Property Trust dated September 1, 2021, which is a related entity.

Stakeholder Impact

• Shareholders: The sale by a CFO, even if pre-planned, could be interpreted by some as a signal, though the Rule 10b5-1 plan mitigates this. The continued significant equity ownership by the CFO suggests ongoing alignment with shareholder interests.
• Employees: The acquisition of shares through the Employee Stock Purchase Plan (ESPP) indicates the continued operation of employee benefit programs.

Next Steps

• Continued vesting of remaining stock options according to the established schedule, with the balance of shares vesting in a series of thirty-six equal monthly installments from the twelve-month anniversary of the Vesting Commencement Date.

Key Dates

Recommendation

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Trading, Stock Option Exercise, Stock Sale, Rule 10b5-1 Plan, Oluyemi Okupe, Chief Financial Officer, Equity Transaction, Beneficial Ownership, Employee Stock Purchase Plan